FY2024 EPS Estimates for Henry Schein, Inc. Boosted by Analyst (NASDAQ:HSIC)

Henry Schein, Inc. (NASDAQ:HSIC - Free Report) - Analysts at Zacks Research raised their FY2024 earnings per share (EPS) estimates for Henry Schein in a research note issued to investors on Tuesday, April 16th. Zacks Research analyst U. Biswas now forecasts that the company will post earnings per share of $5.04 for the year, up from their prior estimate of $5.03. The consensus estimate for Henry Schein's current full-year earnings is $5.07 per share. Zacks Research also issued estimates for Henry Schein's Q4 2025 earnings at $1.37 EPS and FY2025 earnings at $5.38 EPS.

HSIC has been the subject of a number of other reports. Evercore ISI lifted their price objective on Henry Schein from $79.00 to $83.00 and gave the stock an "in-line" rating in a research report on Wednesday, February 28th. JPMorgan Chase & Co. lifted their price objective on Henry Schein from $82.00 to $88.00 and gave the stock an "overweight" rating in a research report on Wednesday, March 6th. SVB Leerink started coverage on Henry Schein in a report on Monday, February 26th. They set a "market perform" rating and a $78.00 target price on the stock. Jefferies Financial Group raised their target price on Henry Schein from $74.00 to $81.00 and gave the stock a "hold" rating in a report on Wednesday, March 6th. Finally, Piper Sandler raised their target price on Henry Schein from $78.00 to $86.00 and gave the stock an "overweight" rating in a report on Monday, February 26th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $81.09.

Henry Schein Trading Down 1.4 %

HSIC stock traded down $1.02 during midday trading on Wednesday, reaching $70.20. The stock had a trading volume of 1,067,027 shares, compared to its average volume of 1,112,613. The business has a fifty day simple moving average of $74.53 and a two-hundred day simple moving average of $72.50. The company has a quick ratio of 1.00, a current ratio of 1.67 and a debt-to-equity ratio of 0.45. The firm has a market cap of $9.02 billion, a price-to-earnings ratio of 22.29, a PEG ratio of 1.75 and a beta of 0.87. Henry Schein has a twelve month low of $60.01 and a twelve month high of $85.39.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Tuesday, February 27th. The company reported $0.66 earnings per share for the quarter, missing analysts' consensus estimates of $0.70 by ($0.04). The business had revenue of $3.02 billion during the quarter, compared to analyst estimates of $3 billion. Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The business's quarterly revenue was down 10.5% compared to the same quarter last year. During the same quarter last year, the business posted $1.21 earnings per share.

Insider Activity

In other news, Vice Chairman James P. Breslawski sold 2,907 shares of Henry Schein stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $74.37, for a total transaction of $216,193.59. Following the transaction, the insider now owns 209,562 shares in the company, valued at approximately $15,585,125.94. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other Henry Schein news, Vice Chairman James P. Breslawski sold 2,907 shares of the business's stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $74.37, for a total value of $216,193.59. Following the sale, the insider now owns 209,562 shares in the company, valued at approximately $15,585,125.94. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Bradford C. Connett sold 6,430 shares of the business's stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the sale, the chief executive officer now owns 73,108 shares in the company, valued at approximately $5,430,462.24. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Henry Schein

Several institutional investors have recently bought and sold shares of the company. McGlone Suttner Wealth Management Inc. acquired a new position in shares of Henry Schein during the 4th quarter worth approximately $39,000. Baystate Wealth Management LLC increased its position in shares of Henry Schein by 2,500.0% during the 3rd quarter. Baystate Wealth Management LLC now owns 520 shares of the company's stock worth $39,000 after purchasing an additional 500 shares during the last quarter. Neo Ivy Capital Management acquired a new position in shares of Henry Schein during the 3rd quarter worth approximately $46,000. Covestor Ltd increased its position in shares of Henry Schein by 88.4% during the 1st quarter. Covestor Ltd now owns 861 shares of the company's stock worth $75,000 after purchasing an additional 404 shares during the last quarter. Finally, Harbour Investments Inc. increased its position in shares of Henry Schein by 27,725.0% during the 4th quarter. Harbour Investments Inc. now owns 1,113 shares of the company's stock worth $84,000 after purchasing an additional 1,109 shares during the last quarter. Institutional investors own 96.62% of the company's stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.